Date published: 2026-2-13

1-800-457-3801

SCBT Portrait Logo
Seach Input

PARP Inhibitor XI, DR2313 (CAS 284028-90-6)

0.0(0)
Write a reviewAsk a question

Application:
PARP Inhibitor XI, DR2313 is a competitive and water soluble PARP inhibitor
CAS Number:
284028-90-6
Purity:
≥98%
Molecular Weight:
182.2
Molecular Formula:
C8H10N2OS
For Research Use Only. Not Intended for Diagnostic or Therapeutic Use.
* Refer to Certificate of Analysis for lot specific data.

QUICK LINKS

PARP Inhibitor XI, DR2313 is a water soluble pyrimidinone compound that functions as a PARP (Poly(ADP-ribose) polymerase) inhibitor. PARP (Poly(ADP-ribose) polymerase) function by triggering DNA repair mechanisms and activating apoptosis in damaged cells. Studies show that DR2313 competes with NAD+ but does not display selectivity among PARP-1 and PARP-2. In addition, in vitro studies of cerebral ischemia exhibiting an overactivation of PARP show that ischemic damage can be reduced by introducing DR2313.


PARP Inhibitor XI, DR2313 (CAS 284028-90-6) References

  1. A newly synthesized poly(ADP-ribose) polymerase inhibitor, DR2313 [2-methyl-3,5,7,8-tetrahydrothiopyrano[4,3-d]-pyrimidine-4-one]: pharmacological profiles, neuroprotective effects, and therapeutic time window in cerebral ischemia in rats.  |  Nakajima, H., et al. 2005. J Pharmacol Exp Ther. 312: 472-81. PMID: 15466246
  2. Structural basis for inhibitor specificity in human poly(ADP-ribose) polymerase-3.  |  Lehtiö, L., et al. 2009. J Med Chem. 52: 3108-11. PMID: 19354255
  3. Bioenergetic metabolites regulate base excision repair-dependent cell death in response to DNA damage.  |  Tang, JB., et al. 2010. Mol Cancer Res. 8: 67-79. PMID: 20068071
  4. Endonuclease G does not play an obligatory role in poly(ADP-ribose) polymerase-dependent cell death after transient focal cerebral ischemia.  |  Xu, Z., et al. 2010. Am J Physiol Regul Integr Comp Physiol. 299: R215-21. PMID: 20427721
  5. Poly(ADP-ribose)glycohydrolase is an upstream regulator of Ca2+ fluxes in oxidative cell death.  |  Blenn, C., et al. 2011. Cell Mol Life Sci. 68: 1455-66. PMID: 20878536
  6. Differential effects of poly(ADP-ribose) polymerase inhibition on DNA break repair in human cells are revealed with Epstein-Barr virus.  |  Ma, W., et al. 2012. Proc Natl Acad Sci U S A. 109: 6590-5. PMID: 22493268
  7. A high content clonogenic survival drug screen identifies mek inhibitors as potent radiation sensitizers for KRAS mutant non-small-cell lung cancer.  |  Lin, SH., et al. 2014. J Thorac Oncol. 9: 965-973. PMID: 24922006
  8. Inhibition of prostaglandin E2 receptor EP3 mitigates thrombin-induced brain injury.  |  Han, X., et al. 2016. J Cereb Blood Flow Metab. 36: 1059-74. PMID: 26661165
  9. Augmentation of poly(ADP-ribose) polymerase-dependent neuronal cell death by acidosis.  |  Zhang, J., et al. 2017. J Cereb Blood Flow Metab. 37: 1982-1993. PMID: 27381826
  10. Poly(ADP-ribose) polymerase inhibitors activate the p53 signaling pathway in neural stem/progenitor cells.  |  Okuda, A., et al. 2017. BMC Neurosci. 18: 14. PMID: 28095779
  11. Targeting Parthanatos in Ischemic Stroke.  |  Koehler, RC., et al. 2021. Front Neurol. 12: 662034. PMID: 34025565
  12. The Identification of a Novel Calcium-Dependent Link Between NAD+ and Glucose Deprivation-Induced Increases in Protein O-GlcNAcylation and ER Stress.  |  Zou, L., et al. 2021. Front Mol Biosci. 8: 780865. PMID: 34950703
  13. Molecular Mechanisms of Parthanatos and Its Role in Diverse Diseases.  |  Huang, P., et al. 2022. Int J Mol Sci. 23: PMID: 35806303

Ordering Information

Product NameCatalog #UNITPriceQtyFAVORITES

PARP Inhibitor XI, DR2313, 5 mg

sc-202756
5 mg
$63.00